Hugues Dolgos is the founder of NMS Group. NMS Group has raised $158M in total funding. Backed by PAG. Based in Nerviano, Italy.
Hugues Dolgos was appointed CEO of NMS Group S.p.A. on January 17, 2022, following a Shareholders’ Meeting that also appointed a new Board of Directors. NMS Group is known for its experienced team and achievements in bringing molecules, such as entrectinib and encorafenib, into marketed drugs. Before joining NMS Group, Dolgos served as Global Head of Oncology at Servier and held notable positions at Merck KGaA and AstraZeneca, focusing on R&D strategy and drug development.
Full founder directory · Investor directory · Company funding database · Fundraising library